Epithelial Mesenchymal Transition in Aggressive Lung Cancers

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Metastasis accounts for over 90% of cancer-related deaths, representing a critical unmet clinical need.
• Epithelial to mesenchymal transition (EMT) is a key developmental process reactivated in cancer, promoting cell mobility, invasion, and resistance to apoptosis.
• EMT also confers stem cell properties and therapeutic resistance to cancer cells, complicating treatment outcomes.

Purpose of the Study:

• To investigate the role of EMT signaling pathways in lung cancer progression.
• To explore the contribution of EMT to cancer stem cell properties and acquired resistance to EGFR tyrosine kinase inhibitors and chemotherapy.
• To discuss the therapeutic potential of targeting EMT pathways in lung cancer.

Main Methods:

• Literature review and synthesis of current research on EMT/MET mechanisms in cancer.
• Analysis of signaling pathways involved in EMT induction and maintenance in lung cancer.
• Discussion of therapeutic strategies targeting EMT in preclinical and clinical settings.

Main Results:

• EMT enhances cancer cell motility, invasion, and survival, facilitating metastatic colonization.
• EMT is linked to the development of cancer stem cells and resistance to targeted therapies and chemotherapy.
• Mesenchymal to epithelial transition (MET) is crucial for disseminated tumor cells to establish macrometastases in distant organs.

Conclusions:

• EMT signaling pathways play a significant role in lung cancer progression, stemness, and therapeutic resistance.
• Targeting EMT pathways presents a promising therapeutic strategy for improving lung cancer treatment outcomes.
• Further research into EMT/MET mechanisms is essential for developing effective anti-metastatic therapies.